| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Johannes Gerardus Christiaan Petrus Schikan | Director | 2026-04-30 | 28,400 | $30.30 | $860.58kSell |
| Peng Lu | Chief Medical Officer | 2026-04-30 | 15,000 | $2.59 | $38.85kBuy |
| Anne Lesage | Chief Early Development | 2026-04-30 | 3,700 | $2.59 | $9.58kBuy |
| Anne Lesage | Chief Early Development | 2026-04-30 | 3,700 | $30.26 | $111.95kSell |
| Anne Lesage | Chief Early Development | 2026-04-30 | 18,000 | $8.05 | $144.90kBuy |
| Anne Lesage | Chief Early Development | 2026-04-30 | 18,000 | $30.26 | $544.61kSell |
| Johannes Gerardus Christiaan Petrus Schikan | Director | 2026-04-30 | 670 | $31.03 | $20.79kSell |
| Anne Lesage | Chief Early Development | 2026-04-30 | 19,200 | $30.26 | $580.92kSell |
| Peng Lu | Chief Medical Officer | 2026-04-30 | 15,000 | $30.24 | $453.63kSell |
| Peng Lu | Chief Medical Officer | 2026-04-29 | 3,733 | $2.59 | $9.67kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| General Atlantic LP | 12.32% | 8,031,252 | $236.44M | Institution |
| Fmr LLC | 9.81% | 6,399,158 | $188.39M | Institution |
| Foresite Capital Management IV LLC | 7.33% | 4,778,581 | $140.68M | Institution |
| Venbio Partners LLC | 7.11% | 4,639,304 | $136.58M | Institution |
| Viking Global Investors LP | 5.60% | 3,653,310 | $107.55M | Institution |
| Eqt Fund Management Sa Rl | 5.25% | 3,424,609 | $100.82M | Institution |
| Deerfield Management Company LP | 4.79% | 3,126,042 | $92.03M | Institution |
| Bain Capital Life Sciences Investors LLC | 4.30% | 2,802,081 | $82.49M | Institution |
| Berndt Modig | 3.13% | 2,039,792 | $60.05M | Insider |
| Wellington Management Group LLP | 2.92% | 1,905,793 | $56.11M | Institution |